Back to all papers

Glioblastoma MRI Dataset with Standardized Preprocessing, Expert-Validated Segmentation, and MGMT Profiling.

August 7, 2026pubmed logopapers

Authors

Filimonova E,Leone A,Carbone F,Zoli M,Rzaev J,Schukina M,Carretta A,Bianconi A,Cofano F,Morello A,Armocida D,Spetzger U,Roumia S,Di Napoli V,Fochi NP,Lau R,Internò V,Giordano G,Curcio A,Rustici A,Angileri F,Mazzatenta D,Signorelli F,Porta C,Garbossa D,Luu MSK,Benedichuk M,Shakoor A,Tuchinov B,Colamaria A

Affiliations (24)

  • Federal Neurosurgical Center, 132/1 Nemirovicha-Danchenko St, Novosibirsk, 630087, Russia.
  • The Artificial Intelligence Research Center of Novosibirsk State University, 1 Pirogov St, Novosibirsk, 630090, Russia.
  • Department of Neurosurgery, Städtisches Klinikum Karlsruhe, Karlsruher Neurozentrum, Karlsruhe, Germany.
  • Department of Neurosurgery, Städtisches Klinikum Karlsruhe, Karlsruher Neurozentrum, Karlsruhe, Germany. [email protected].
  • Division of Neurosurgery, University Hospital of Foggia, Foggia, Italy. [email protected].
  • Department of Biomedical and Neuromotor Sciences (DIBINEM), "Alma Mater Studiorum" University of Bologna, Bologna, Italy.
  • IRCCS Istituto delle Scienze Neurologiche di Bologna, Programma Neurochirurgia Ipofisi-Pituitary Unit, Bologna, Italy.
  • Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genova, 16132, Genova, Italy.
  • Department of Neurosurgery, IRCCS Ospedale Policlinico San Martino, Genova, 16132, Genoa, Italy.
  • Department of Neurosurgery, AOU Città della Salute e della Scienza, Turin, Italy.
  • Department of Neurosurgery, University of Turin, Turin, Italy.
  • Institute for Anthropomatics and Robotics, Karlsruhe Institute for Technology - KIT, Karlsruhe, Germany.
  • Department of Radiology, Division of Neuroradiology, Städtisches Klinikum Karlsruhe, Karlsruhe, Germany.
  • Neurosurgery Department, Hospital Universitari Joan XXIII, Tarragona, Spain.
  • Universitat Rovira i Virgili, Tarragona, Spain.
  • Division of Medical Oncology, A.O.U. Consorziale Policlinico Di Bari, Bari, Italy.
  • Unit of Medical Oncology and Biomolecular Therapy and CREATE Center for Research and Innovation Medicine, Department of Medical and Surgical Sciences, University of Foggia, Policlinico Riuniti, Foggia, Italy.
  • Fondazione IRCCS Casa Sollievo della Sofferenza, UOC di Neurochirurgia, San Giovanni Rotondo, Italy.
  • Neuroradiology Unit, Ospedale Maggiore, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
  • Department of Biomedical Sciences, Dental Sciences and Morpho-functional Imaging, University of Messina, Messina, Italy.
  • Division of Neurosurgery, Department of Translational Biomedicine and Neurosciences, University "Aldo Moro" of Bari, Bari, Italy.
  • Interdisciplinary Department of Medicine, University of Bari "Aldo Moro" and Division of Medical Oncology, A.O.U. Consorziale Policlinico Di Bari, Bari, Italy.
  • The Artificial Intelligence Research Center of Novosibirsk State University, 1 Pirogov St, Novosibirsk, 630090, Russia. [email protected].
  • Division of Neurosurgery, University Hospital of Foggia, Foggia, Italy.

Abstract

Glioblastoma research increasingly relies on large, well-curated imaging datasets that combine standardized MRI data, accurate tumor segmentations, and molecular profiling. We constructed a multi-center dataset of preoperative MRI scans from 337 patients with histologically confirmed primary glioblastoma collected across eight hospitals. All cases include T1-weighted (pre- and post-contrast), T2-weighted, and FLAIR sequences. Images underwent systematic quality assessment, BIDS organization, defacing, skull stripping, and linear registration to the MNI152 template. Tumor segmentation was performed using a SegResNet CNN model following the BraTS labeling convention, with all masks reviewed and manually refined by neuroradiologists. MGMT promoter methylation status was determined for all patients. This dataset provides a robust, clinically representative resource for radiomics, deep learning, and radiogenomic research in glioblastoma, supporting concrete downstream tasks including automated segmentation benchmarking (mean Dice = 0.94) and MGMT methylation prediction (baseline ACC = 0.60). Its multi-center origin, comprehensive preprocessing, expert-refined segmentations, and complete MGMT annotations address limitations of existing datasets and support the development and validation of reproducible imaging biomarkers.

Topics

GlioblastomaDNA Modification MethylasesDNA Repair EnzymesTumor Suppressor ProteinsMagnetic Resonance ImagingBrain NeoplasmsJournal ArticleDataset

Ready to Sharpen Your Edge?

Subscribe to join 11k+ peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.